Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-04-08 6:19 pm |
N/A N/A |
LAVA Therapeutics NV | LVTX | Cooperatieve Gilde Healthcare IV U.A. Gilde Healthcare IV Management B.V. Gilde Healthcare Holding B.V. 10% Owner |
0 | $0 | 5,421,170 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-02-12 |
LAVA Therapeutics NV | LVTX | WILSON KAREN J Director |
33,390 | $0 | 33,390 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-02-12 |
LAVA Therapeutics NV | LVTX | Wadlinger Mary E. Director |
33,390 | $0 | 33,390 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-02-12 |
LAVA Therapeutics NV | LVTX | Noble James Director |
33,390 | $0 | 33,390 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-02-12 |
LAVA Therapeutics NV | LVTX | Kiener Peter A Director |
33,390 | $0 | 33,390 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-02-12 |
LAVA Therapeutics NV | LVTX | Backstrom Jay T. Director |
33,390 | $0 | 33,390 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-02-12 |
LAVA Therapeutics NV | LVTX | Dhingra Kapil Director |
33,390 | $0 | 33,390 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-03-12 |
LAVA Therapeutics NV | LVTX | Powell Fred M Chief Financial Officer |
124,700 | $0 | 124,700 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-03-12 |
LAVA Therapeutics NV | LVTX | Morris Charles Q Chief Medical Officer |
130,850 | $0 | 130,850 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-02-12 |
LAVA Therapeutics NV | LVTX | Oliger Christy J. Director |
33,390 | $0 | 33,390 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 8:15 pm |
N/A 2035-03-12 |
LAVA Therapeutics NV | LVTX | HURLY STEPHEN A Chief Executive Officer |
335,100 | $0 | 335,100 (Direct) |
View |
Ownership |
2025-02-06 7:29 pm |
N/A N/A |
LAVA Therapeutics NV | LVTX | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
0 | $0 | 4,587,837 (Direct) |
View |
Ownership |
2025-01-02 09:35 am |
N/A N/A |
LAVA Therapeutics NV | LVTX | WILSON KAREN J Director |
0 | $0 | 107,651 (Direct) |
View |
Ownership |
2025-01-02 09:34 am |
N/A 2033-03-09 |
LAVA Therapeutics NV | LVTX | Wadlinger Mary E. Director |
0 | $0 | 53,390 (Direct) |
View |
Ownership |
2025-01-02 09:32 am |
N/A 2033-03-09 |
LAVA Therapeutics NV | LVTX | Oliger Christy J. Director |
0 | $0 | 53,390 (Direct) |
View |
Ownership |
2025-01-02 09:31 am |
N/A 2032-12-22 |
LAVA Therapeutics NV | LVTX | Noble James Director |
0 | $0 | 73,390 (Direct) |
View |
Ownership |
2025-01-02 09:29 am |
N/A 2033-03-09 |
LAVA Therapeutics NV | LVTX | Kiener Peter A Director |
0 | $0 | 53,390 (Direct) |
View |
Ownership |
2025-01-02 09:28 am |
N/A 2032-12-22 |
LAVA Therapeutics NV | LVTX | Backstrom Jay T. Director |
0 | $0 | 73,390 (Direct) |
View |
Ownership |
2025-01-02 09:26 am |
N/A N/A |
LAVA Therapeutics NV | LVTX | Dhingra Kapil Director |
0 | $0 | 311,130 (Direct) |
View |
Ownership |
2025-01-02 09:21 am |
N/A 2033-02-05 |
LAVA Therapeutics NV | LVTX | Morris Charles Q Chief Medical Officer |
0 | $0 | 370,400 (Direct) |
View |
Ownership |
2025-01-02 09:20 am |
N/A N/A |
LAVA Therapeutics NV | LVTX | Powell Fred M Chief Financial Officer |
0 | $0 | 380,950 (Direct) |
View |
Ownership |
2025-01-02 09:19 am |
N/A N/A |
LAVA Therapeutics NV | LVTX | HURLY STEPHEN A Chief Executive Officer |
0 | $0 | 2,152,963 (Direct) |
View |